UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 149

Sortiert nach

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

The Journal of infectious diseases, 2009-03, Vol.199 (6), p.805-814

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

Pediatrics (Evanston), 2016-08, Vol.138 (2)

2016

Link zum Volltext

Verfügbarkeit prüfen

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Cancer epidemiology, biomarkers & prevention, 2014-10, Vol.23 (10), p.1997-2008

2014

Link zum Volltext

Verfügbarkeit prüfen

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease

Vaccines (Basel), 2021-01, Vol.9 (2), p.83

2021

Link zum Volltext

Verfügbarkeit prüfen

Rate of Involved Endocervical Margins According to High-Risk Human Papillomavirus Subtype and Transformation Zone Type in Specimens with Cone Length ≤ 10 mm versus > 10 mm—A Retrospective Analysis

Life (Basel, Switzerland), 2023-08, Vol.13 (8), p.1775

2023

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (5), p.2078626-2078626

2022

Link zum Volltext

Verfügbarkeit prüfen

SPERANZA project: HPV vaccination after treatment for CIN2

Gynecologic oncology, 2018-11, Vol.151 (2), p.229-234

2018

Link zum Volltext

Verfügbarkeit prüfen

HPV screening in the urine of transpeople - A prevalence study

EClinicalMedicine, 2022-12, Vol.54, p.101702-101702, Article 101702

2022

Link zum Volltext

Verfügbarkeit prüfen

Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial

The Lancet (British edition), 2022-05, Vol.399 (10337), p.1790-1798

2022

Link zum Volltext

Verfügbarkeit prüfen

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee

International journal of gynecological cancer, 2022-07, Vol.32 (10), p.1316-1320

2022

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer

Vaccine, 2023-10, Vol.41 (42), p.6194-6205

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trial Experience With Prophylactic Human Papillomavirus 6/11/16/18 Vaccine in Young Black Women

Journal of adolescent health, 2013-03, Vol.52 (3), p.322-329

2013

Link zum Volltext

Verfügbarkeit prüfen

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Vaccine, 2021-04, Vol.39 (16), p.2224-2236

2021

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy

European journal of cancer (1990), 2019-07, Vol.116, p.21-26

2019

Link zum Volltext

Verfügbarkeit prüfen

The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018-2019)

Expert review of vaccines, 2020-11, Vol.19 (11), p.1073-1083

2020

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus Infections and Vulvar Disease Development

Cancer epidemiology, biomarkers & prevention, 2009-06, Vol.18 (6), p.1777-1784

2009

Link zum Volltext

Verfügbarkeit prüfen

Human papilloma virus infection prior to coitarche

American journal of obstetrics and gynecology, 2009-05, Vol.200 (5), p.487.e1-487.e5

2009

Link zum Volltext

Verfügbarkeit prüfen

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

Gynecologic oncology, 2019-07, Vol.154 (1), p.110-117

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for human papillomavirus infection and disease: A targeted literature summary

Journal of medical virology, 2024-02, Vol.96 (2), p.e29420-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study

International journal of cancer, 2015-12, Vol.137 (12), p.2858-2868

2015

Link zum Volltext

Verfügbarkeit prüfen

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

International journal of cancer, 2013-02, Vol.132 (4), p.854-867

2013

Link zum Volltext

Verfügbarkeit prüfen

The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials

International journal of cancer, 2011-03, Vol.128 (6), p.1354-1362

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(148)
Buchkapitel
(1)

Sprache

Englisch
(145)
Japanisch
(15)
Deutsch
(4)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(113)
Humans
(105)
Female
(103)
Adult
(59)
Human Papillomavirus
(55)
Obstetrics & Gynecology
(47)
Biological And Medical Sciences
(45)
Medical Sciences
(44)
Middle Aged
(37)
Adolescent
(35)
Oncology
(33)
Cervical Cancer
(32)
Papillomavirus Infections - Prevention & Control
(32)
Young Adult
(28)
Gynecology. Andrology. Obstetrics
(24)
Pregnancy
(24)
Vaccines
(24)
Aged
(23)
Tumors
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease

Rate of Involved Endocervical Margins According to High-Risk Human Papillomavirus Subtype and Transformation Zone Type in Specimens with Cone Length ≤ 10 mm versus > 10 mm—A Retrospective Analysis

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years

SPERANZA project: HPV vaccination after treatment for CIN2

HPV screening in the urine of transpeople - A prevalence study

Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer

Clinical Trial Experience With Prophylactic Human Papillomavirus 6/11/16/18 Vaccine in Young Black Women

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy

The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018-2019)

Human Papillomavirus Infections and Vulvar Disease Development

Human papilloma virus infection prior to coitarche

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

Risk factors for human papillomavirus infection and disease: A targeted literature summary

Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study

Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study

The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials

Suchergebnisse filtern